Johns Hopkins University School of Medicine;
Baltimore;
USA;
Department of Neurosurgery;
Johns Hopkins Hospital;
Johns Hopkins University School of Medicine;
Baltimore;
USA;
Cancer; Glioblastoma Management; Treatment Response; Prognosis; Pseudoprogression; Biomarker; Microbiome; Immunotherapy; Chemotherapy;